<DOC>
	<DOCNO>NCT00548080</DOCNO>
	<brief_summary>Registration study</brief_summary>
	<brief_title>Evaluate Safety Efficacy Caspofungin Acetate Empirical Therapy Chinese Adults With Persistent Fever Neutropenia ( 0991-055 )</brief_title>
	<detailed_description />
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Caspofungin</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<criteria>Patient absolute neutrophil count &lt; 500/mm3 least 96 hour ( patient must expect recover neutropenia next 48 hour ) , receive least 96 hour parenteral broad spectrum systemic antibacterial therapy precede study entry , patient fever &gt; 38.0 Degrees Centigrade within last 24 hour prior study entry Appropriate antibiotic provide broad spectrum grampositive gramnegative coverage Patient inadequately manage bacterial infection time enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>